Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
Published: December 2021This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.
TIP 63: Medications for Opioid Use Disorder - Executive Summary
Published: August 2021The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
TIP 63: Medications for Opioid Use Disorder - Full Document
Published: July 2021This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders
Published: June 2021This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.
Use of Medication-Assisted Treatment in Emergency Departments
Advisory: Addressing Suicidal Thoughts and Behaviors in Substance Use Treatment
Advisory: Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder
Published: January 2021This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.
Preventing the Use of Marijuana: Focus on Women and Pregnancy
Published: December 2019This guide supports health care providers, systems, and communities seeking to prevent marijuana use by pregnant women. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
Screening and Assessment of Co-Occurring Disorders in the Justice System
Published: June 2019This report provides evidence-based practices for screening and assessment of adults in the justice system with mental illness, substance use disorders, or both. It discusses the importance of instrument selection for screening and assessment and provides detailed descriptions of recommended instruments.